 |
||||||||
 |
|
 |
 |
 |
 |
 |
|
|
|
Brian M. Gallagher, Jr. - PartnerBrian joined SR One in 2010 and setup the Boston office. He is currently a member of the Board of Directors of Aileron Therapeutics and SpringLeaf Therapeutics, and is an observer on the Boards of Constellation Pharmaceuticals and Dicerna Pharmaceuticals. Brian has nearly 15 years of business development, operational and R&D experience in both biotech and large pharma companies. He most recently led corporate development and business operations at Sirtris Pharmaceuticals, which was acquired by GSK in 2008. Prior to Sirtris, he was with Alantos Pharmaceuticals (acquired by Amgen), and he began his career in R&D at the Japanese pharma Eisai, where he initiated and led multiple programs and scientific teams. Brian received his M.S. and Ph.D. degrees in Organic Chemistry from The University of Michigan, and a B.S. in Chemistry from The University of Massachusetts, where he was awarded a full scholarship.
|
|